Vera Therapeutics VERA
$25.45 −$1.30 (-4.86%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $24.88 -2.24%
Open$26.37
Prev close$26.75
Day range$25.16 – $27.15
Volume1.37M
Market cap$1.84B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts12
Average target$70.20+175.8% vs. price
- Buy 83%
- Hold 17%
Low $34.00Now $25.45Avg $70.20High $100.00
Recent rating changes
The last 20 actions on file set price targets from $34.00 to $100.00, averaging $69.78.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 12 Nov 2026 | J.P. Morgan | BUY | $75.00 |
| 6 Nov 2026 | BofA Securities | BUY | – |
| 6 Nov 2026 | H.C. Wainwright | BUY | $75.00 |
| 5 Nov 2026 | Cantor Fitzgerald | BUY | $100.00 |
| 5 Nov 2026 | Guggenheim | BUY | $66.00 |
| 30 Oct 2026 | Guggenheim | BUY | $76.00 |
| 27 Oct 2026 | Leerink Partners | HOLD | $34.00 |
| 23 Oct 2026 | Cantor Fitzgerald | BUY | $100.00 |
| 23 Oct 2026 | BofA Securities | BUY | $60.00 |
| 23 Oct 2026 | Wedbush | HOLD | $34.00 |
| 23 Oct 2026 | Guggenheim | BUY | $76.00 |
| 22 Oct 2026 | Goldman Sachs | BUY | $80.00 |
| 15 Oct 2026 | Wells Fargo | BUY | $70.00 |
| 9 Oct 2026 | BofA Securities | BUY | $60.00 |
| 1 Oct 2026 | H.C. Wainwright | BUY | $90.00 |
| 16 Sep 2026 | Wedbush | HOLD | $34.00 |
| 15 Sep 2026 | Wells Fargo | BUY | $70.00 |
| 15 Sep 2026 | LifeSci Capital | BUY | $90.00 |
| 15 Sep 2026 | Raymond James | BUY | – |
| 15 Sep 2026 | BofA Securities | BUY | $66.00 |
No comments yet — be the first to weigh in on VERA.
Sign in to join the discussion.